OmniTier
Private Company
Funding information not available
Overview
Founded in 2018 and headquartered in San Francisco, OmniTier is a private computational biology company focused on delivering affordable, on-premise genomic analysis solutions. Its core technology leverages memory-centric computing and AI to accelerate and improve the accuracy of variant calling and interpretation, targeting clinical diagnostics and research. The company offers standalone appliances, such as the CompStor series, which aim to reduce analysis costs and time while maintaining data security and control for its customers.
Technology Platform
Memory-centric high-performance computing software stack integrated with AI-powered workflows for genomic secondary and tertiary analysis, deployed on standalone on-premise appliances.
Opportunities
Risk Factors
Competitive Landscape
OmniTier competes against large cloud infrastructure providers (AWS, Google Cloud, Microsoft Azure), specialized bioinformatics SaaS platforms (DNAnexus, Seven Bridges, Pierian), and the analysis tools bundled by sequencing instrument companies (Illumina DRAGEN, PacBio). Its key differentiation is the integrated on-premise appliance offering lower operational costs and enhanced data control.